Dr. Aslam M Khaja is an Assistant Professor in the Department of Neurology and Rehabilitation. His clinical and research interests include cerebrovascular disease and neurological critical care.
Dr. Khaja is also the Neurology clerkship director. The University of Illinois at Chicago is the largest medical school in the country, and all medical students must rotate through the neurology department for 2 weeks. He supervises the clerkship experience and ensures that students learn important aspects of the neurological examination and common neurological conditions.
Dr. Khaja is board eligible in Neurology by the American Board of Psychiatry and Neurology. He also plans to become boarded in the specialties of Vascular Neurology and Neurological Critical Care.
Dr Khaja received his medical degree from the Northeasern Ohio Universities College of Medcine in 2001. He completed his medical internship at the Oschner Clinic in New Orleans, LA in 2002. He completed his Neurology Residency at the University of Cincinnati in 2005. He then completed a 2 year fellowship in stroke at the University of Texas-Houston in 2007.
Dr. Khaja joined the department 2007, and is the most recent addition to the stroke and neurological critical care section. He splits his time between the inpatient stroke service and the Neurosurgical ICU. His clinical research interests focus on acute ischemic stroke treatments, particularly thrombolysis. He has presented his research at multiple national and international conferences.
Khaja AM, Grotta JC. Established Treatments for Acute Ischaemic Stroke. Lancet 369(9558):319-330, January 2007.
Martin-Schild S, Hallevi H, Albright KC, Khaja AM, Barreto AD, Gonzales NR, Grotta JC, Savitz SI. Aggressive Blood Pressure-lowering Treatment Before Intravenous Tissue Plasminogen Activator Therapy in Acute Ischemic Stroke. Arch Neurol 65(9):1174-1178, September 2008
Barreto AD, Albright KC, Hallevi H, Grotta JC, Noser EA, Khaja AM, Shaltoni HM, Gonzales NR, Illoh K, Martin-Schild S, Campbell MS, Wier RU, Savitz SI. Thrombus Burden Is Associated with Clinical Outcome After Intra-Arterial Therapy for Acute Ischemic Stroke. Stroke 2008(39):000-000, September 2008
Hallevi H, Gonzales NR, Barreto AD, Martin-Schild S, Albright KC, Noser EA, Illoh K, Khaja AM, Allison T, Escobar MA, Shaltoni HM, Grotta JC. The Effect of Activated Factor VII for Intracerebral Hemorrhage Beyond 3 Hours Versus Within 3 Hours. Stroke 39(2):473-475, February 2008
Khaja AM, Martin-Schild S, Albright KC, Gonzales NR, Barreto AD, Hallevi H, Noser EA, Illoh K, Grotta JC.Cocaine and Acute Ischemic Stroke: Observations from the UT-Houston Stroke Registry. Poster Presentation for 59th Annual Meeting of the American Academy of Neurology. April 2007.
Shaltoni HM, Barreto AD, Albright KC, Noser EA, Khaja AM, Gonzales NR, Martin-Schild S, Hallevi H, Illoh K, Grotta JC, Weir RU. Acute Carotid Occlusion Treated With and Without MERCI Retriever Device: The Houston Experience. Oral Presentation for the 45th Annual Meeting of the American Society of Neuroradiology. June 2007
Khaja AM, Merrick MT, Noser EA, Albright KC, Gonzales NR, Barreto AD, Martin-Schild S, Hallevi H, Illoh K, Shaltoni HM, Grotta JC. Development of Orolingual Angioedema in Ischemic Stroke Patients Treated with Intravenous Tissue Plasminogen Activator. Poster presentation for 31st International Stroke Conference. February 2007.